LIBIDO ELLE ET LUI
Food supplement declared in France, declaration No 2020-7-878, decision dated 20 July 2020
LIBIDO ELLE ET LUI (SYNERVITAL) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 3 rules of use apply to its ingredients (limits and warnings).
- Brand
- SYNERVITAL
- Food business operator placing the product on the market
- IEDBS
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 4 à 6 gélules jour
- Directions for use
- avec un grand verre d'eau.
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Antécédent de cancer du sein, Enfants en bas âge (1 à 3 ans), Femmes enceintes, Sous antidiabétiques, Sous traitement antihypertenseur
Declaration 307887, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Turnera diffusa Willd. ex Schult.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Lepidium meyenii Walp. | Racine | Poudre (de plantes séchées ou broyées) | 600 mg |
| Turnera diffusa Willd. ex Schult. | Feuille | Poudre (de plantes séchées ou broyées) | 570 mg |
| Tribulus terrestris L. | Fruit | Extrait sec hydroalcoolique | 450 mg |
| Satureja hortensis L. | Feuille | Poudre (de plantes séchées ou broyées) | 150 mg |
| Panax ginseng C.A.Mey. | Racine | Poudre (de plantes séchées ou broyées) | 120 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Levure enrichie en sélénium | Sélénium | 255 µg | 50 µg |
| Sulfate de zinc | Zinc | 25 mg | 15 mg |
Additives
E470b
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Lepidium meyenii Walp.
Read the warning, when it applies and the studies cited
Maca - Lepidium Meyenii
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Applies to products providing 0.6 g or more dried root/hypocotyl, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a blood pressure condition (Valentova et al. 2008).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Healthy mood balance; Sexual health.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression (Brotto 2010; Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Tribulus terrestris L.
Read the warning, when it applies and the studies cited
TRIBULUS - TRIBULUS TERRESTRIS
Route of administration: Oral
Cautions and warnings
Condition of application: All products except Vrsya (aphrodisiac for men).
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Chen and Chen 2004).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Traditional Chinese Medicine.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have qi or blood deficiency (Bensky et al. 2004).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use if you have low blood pressure or liver deficiency (Bensky et al. 2004; Chen and Chen 2004).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occurs (Bensky et al. 2004)
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: All products except Mutrala (diuretic).
When using this product diuretic effect may occur.
- Panax ginseng C.A.Mey.
Read the warning, when it applies and the studies cited
PANAX GINSENG
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Vuksan et al. 2008; Seely et al. 2008; Sievenpiper et al. 2006; ESCOP 2003; Tetsutani et al. 2000; Sotaniemi et al. 1995; Chin 1991).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking antidepressant medication, blood thinners or digoxin (Brinker 2010; Lee et al. 2008a; Dasgupta and Reyes 2005; Janetzki and Morreale 1997; Gonzalez-Seijo et al. 1995; Shader and Greenblatt 1988; Jones and Runikis 1987; Shader and Greenblatt 1985).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use in cases of yin deficiency with heat signs, heat excess, or in the absence of significant qi deficiency (Bensky et al. 2004).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience insomnia, anxiety or headaches (Lee et al. 2008b; Vuksan et al 2008; de Andrade et al.2007; Sievenpiper et al. 2006; Coon and Ernst 2002; Ellis and Reddy 2002; Scaglione et al. 2001; Siegel 1979).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- LIBIDO ELLE ET LUI Phyraflor, declared in 2019 : same declared composition
Brand : SYNERVITAL
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.